Target-controlled infusion vs patient-controlled sedation with propofol in ERCP.

• Conditions: elective ERCP(endoscopic retrograde cholangiopancreatography) patients; MedDRA version: 12.0Level: HLGTClassification code 10019654Term: Hepatic and hepatobiliary disorders; MedDRA version: 12.0Level: HLTClassification code 10019808Term: Hepatobiliary imaging procedures; MedDRA version: 12.0Level: HLTClassification code 10027692Term: Pancreatic disorders NEC

• Registration Number: EUCTR2009-015564-34-FI
• Lead Sponsor: Helsinki University Central hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-12-28
• Last Update Posted: 24 November 2014

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

-elective ERCP-patients of age 18-75 and ASA class 1-3
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

-allergy to propofol or alfentanyl
-pregnancy
-inability to cooperate

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified